IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity (2014)
Bassères, Daniela Sanchez 
; Ebbs, Aaron; Cogswell, Patricia C; Baldwin, Albert S
Source: Genes & Cancer. Unidade: IQ
Subjects: ONCOGENES, NEOPLASIAS DO TRATO RESPIRATÓRIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASSÈRES, Daniela Sanchez et al. IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity. Genes & Cancer, v. 5, n. 1-2, p. 41-55, 2014Tradução . . Disponível em: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063255/pdf/ganc-05-041.pdf. Acesso em: 11 nov. 2024.APA
Bassères, D. S., Ebbs, A., Cogswell, P. C., & Baldwin, A. S. (2014). IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity. Genes & Cancer, 5( 1-2), 41-55. Recuperado de http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063255/pdf/ganc-05-041.pdfNLM
Bassères DS, Ebbs A, Cogswell PC, Baldwin AS. IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity [Internet]. Genes & Cancer. 2014 ; 5( 1-2): 41-55.[citado 2024 nov. 11 ] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063255/pdf/ganc-05-041.pdfVancouver
Bassères DS, Ebbs A, Cogswell PC, Baldwin AS. IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity [Internet]. Genes & Cancer. 2014 ; 5( 1-2): 41-55.[citado 2024 nov. 11 ] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063255/pdf/ganc-05-041.pdf
